Korea Enhances Pandemic Response with Formalized Vaccine System

Published: 2026/01/08 02:28:48

South Korea has solidified its preparedness for future pandemic crises by establishing a legally mandated, government-wide system for the rapid deployment of vaccines. This new framework, formalized through the “Regulations on the Establishment and Operation of the Pan-Government Consultative Body for Vaccine Introduction”[2], aims to streamline the process of securing and utilizing both domestically produced and internationally developed vaccines.

From Reactive to Proactive: Lessons Learned from COVID-19

The impetus for this formalized system stems from experiences during the COVID-19 pandemic. While a temporary, government-wide consultative body was established early in the pandemic, it lacked a firm legal foundation, hindering its capacity as a sustained, proactive response mechanism. The newly enacted regulations address this gap by creating a permanent and standardized approach to future public health emergencies.

How the System Works: A Multi-Ministry Approach

The pan-government consultative body is activated when the nation’s crisis alert level rises above ‘alert’ due to the emergence of a new infectious disease. This body assumes critical responsibilities,including:

• Establishing and coordinating national vaccine supply and demand projections.
• Facilitating information sharing related to vaccine licensing and approval processes.
• Monitoring global vaccine supply and demand trends.
• Coordinating implementation plans across various government ministries.

The body is chaired by the Director of the Korea Disease Control and prevention Agency (KDCA), with key participation from representatives of the Ministry of foreign Affairs, Ministry of Health and Welfare, Ministry of Planning and Budget, Office for Government Policy Coordination, and Ministry of Food and Drug Safety.

Strengthened Prior Review and Collaboration

To further enhance efficiency, a parallel working-level consultative body will operate alongside the main committee. This council,comprised of deputy directors from the KDCA and directors from participating ministries,will focus on strengthening prior review processes and practical interagency cooperation.The chairperson of both bodies has the authority to request data, opinions, and personnel support from relevant institutions and organizations when necessary.

Investment in Pandemic Preparedness

Korea is also increasing its financial commitment to pandemic preparedness. A recent investment of $18.9 million in the Coalition for Epidemic preparedness Innovations (CEPI) [[1]] will contribute to CEPI 3.0, a plan focused on reducing the time it takes to develop and deliver vaccines in response to future pandemics – aiming for deployment within 100 days of identifying a new “Disease X.” This represents significantly faster vaccine development than was possible during the initial stages of the COVID-19 pandemic.

Korea’s Broader Pandemic Strategy

Beyond vaccine access, South Korea prioritizes extensive epidemic preparedness, including significant investment in vaccine research and development through public-private partnerships [2]. National firms are currently developing vaccines for a range of threats, including influenza, emerging COVID-19 variants, and zoonotic diseases like avian flu and MERS. Korea also aligns its pandemic prevention,preparedness,and response efforts with global initiatives focused on Universal Health Coverage (UHC) [[3]], recognizing the critical link between health security and global health architecture.

KDCA Director lim Seung-kwan emphasized the importance of this collaborative framework, stating that it will “greatly contribute to the early end of the infectious disease pandemic in the future.”